Abstract

Lansoprazole 3-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2007 - Pediatric Patients

Page(s): 74

Download in electronic PDF format for $75

Abstract

A formulation for preparing Lansoprazole 3-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2011 Pg. 124-128	Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Author(s): Corsini Lindsay, Williams LaVonn A
Jan/Feb 2007 Pg. 74	Lansoprazole 3-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 246	Lansoprazole 3-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2022 Pg. 429	Lansoprazole 3-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 58	Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 263	Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension Author(s):
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
Nov/Dec 2019 Pg. 504-510	Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Sep/Oct 2006 Pg. 389	Omeprazole 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 391	Pantoprazole Sodium 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 500-512	To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Author(s): Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Jan/Feb 2025 Pg. 46	Lansoprazole 3-mg/mL Oral Suspension Author(s):
May/Jun 2023 Pg. 250-255	Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base Author(s): Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
Sep/Oct 2006 Pg. 382	Famotidine 8-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 161	Ranitidine Hydrochloride 15-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 140-147	The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment Author(s): Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Nov/Dec 2005 Pg. 423-431	Compounding for a Pediatric Hospital Author(s): McElhiney Linda F